论文部分内容阅读
Germline activating mutations of protein tyrosine phosphatase PTPN11(Shp2),a positive regulator of the Ras signaling pathway,are associated with 50%of patients with Noonan syndrome.These patients have an increased risk of developing leukemias,especially juvenile myelomonocytic leukemia(JMML),a childhood myeloproliferative neoplasm(MPN).